Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cencora, Inc.COR · Entity 2994 | Executive Vice President | June 30, 2026 | July 07, 2026 |
| agilon health, inc.AGL · Entity 4698 | Director | June 02, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cencora, Inc.
Report date June 30, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,624.012 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 58.204 · Balance 23,624.012 F1: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Filing footnotes · ownership attribution and instrument terms
F1: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c) and Rule 16b-3(d).
agilon health, inc.
Report date June 02, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,926 |
Reported balance
After 2026-06-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 2,133 · Balance 7,926 F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.
F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
F3: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 7, 2026 20:01 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 58.204 | $240.53 | $13,999.98 |
DisclosureSEC source: 0001774724-26-000006 · wk-form4_1783454488.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,624.012 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:55 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-041020 · wk-form4_1780624523.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,926 F1 · shares: Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. F3 · balance_after: Includes restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:17 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 8,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001774724-26-000004 · wk-form4_1773433030.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,415 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest March 11, 2026. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest March 11, 2026. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest March 11, 2026. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:17 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 3,673 | $350.30 | $1,286,651.90 |
DisclosureSEC source: 0001774724-26-000004 · wk-form4_1773433030.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,565.808 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:17 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 8,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001774724-26-000004 · wk-form4_1773433030.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,238.808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest March 11, 2026. Read SEC document |
| December 31, 2025 Filed Jan 7, 2026 21:00 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 27.344 | $287.09 | $7,850.13 |
DisclosureSEC source: 0001774724-26-000002 · wk-form4_1767819651.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,823.808 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| December 19, 2025 Filed Dec 22, 2025 21:15 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 1,677 | $345.00 | $578,565.00 |
DisclosureSEC source: 0001774724-25-000011 · wk-form4_1766438156.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,796.464 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:09 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 932 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001774724-25-000009 · wk-form4_1764022169.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,865 Underlying: Common Stock · 932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F1 · derivative.exercise_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F1 · derivative.expiration_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:09 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 406 | $362.07 | $147,000.42 |
DisclosureSEC source: 0001774724-25-000009 · wk-form4_1764022169.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,473.464 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:09 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 932 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001774724-25-000009 · wk-form4_1764022169.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,879.464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:04 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 5,612 | $312.53 | $1,753,918.36 |
DisclosureSEC source: 0001774724-25-000007 · wk-form4_1763154280.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,947.464 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of performance share units. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:04 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 12,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001774724-25-000007 · wk-form4_1763154280.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,559.464 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:04 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001774724-25-000007 · wk-form4_1763154280.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,202 Underlying: Common Stock · 2,202 shares Expires not disclosed F3 · derivative.exercise_price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/12/2026, 11/12/2027 and 11/12/2028. F3 · derivative.exercise_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/12/2026, 11/12/2027 and 11/12/2028. F3 · derivative.expiration_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/12/2026, 11/12/2027 and 11/12/2028. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · derivative · entry 6 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,085 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F3 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F3 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,265 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · derivative · entry 5 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,265 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 473 | $360.70 | $170,611.10 |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · nonDerivative · entry 4 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,674.464 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · nonDerivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,147.464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 551 | $360.70 | $198,745.70 |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,063.464 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:31 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001774724-25-000005 · wk-form4_1762983094.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,614.464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| June 30, 2025 Filed Jul 7, 2025 20:02 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 52.575 | $254.87 | $13,399.95 |
DisclosureSEC source: 0001140859-25-000115 · wk-form4_1751918550.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,349.464 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:06 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 4,077 | $297.41 | $1,212,520.19 |
DisclosureSEC source: 0001140859-25-000109 · wk-form4_1750449997.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,296.889 Read SEC document |
| May 28, 2025 Filed May 30, 2025 22:23 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 78,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028713 · wk-form4_1748643718.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,868 F1 · shares: Restricted stock units that vest in full on May 28, 2026, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 22:25 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 5,000 | $242.24 | $1,211,200.00 |
DisclosureSEC source: 0001140859-25-000036 · wk-form4_1740435950.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,373.889 Read SEC document |
| December 31, 2024 Filed Jan 13, 2025 21:26 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 44.809 | $190.98 | $8,557.53 |
DisclosureSEC source: 0001140859-25-000004 · wk-form4_1736803600.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,373.889 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 20:47 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 1,678 | $228.72 | $383,792.16 |
DisclosureSEC source: 0001140859-24-000193 · wk-form4_1734986832.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,329.08 Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:31 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 25,062 | $2.01 | $50,269.36 |
DisclosureSEC source: 0001628280-24-051235 · wk-form4_1734129078.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,144 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.995 to $2.010, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:14 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 6,218 | $225.08 | $1,399,547.44 |
DisclosureSEC source: 0001140859-24-000168 · wk-form4_1732310063.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,007.08 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of performance share units. Read SEC document |
| November 21, 2024 Filed Nov 22, 2024 21:14 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 14,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000168 · wk-form4_1732310063.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,225.08 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:14 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 2,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000168 · wk-form4_1732310063.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,797 Underlying: Common Stock · 2,797 shares Expires not disclosed F3 · derivative.exercise_price: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F3 · derivative.exercise_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. F3 · derivative.expiration_date: Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · derivative · entry 9 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,169 Underlying: Common Stock · 1,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F4 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F4 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,264 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · derivative · entry 8 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,265 Underlying: Common Stock · 1,264 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 2,971 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · derivative · entry 7 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 473 | $248.41 | $117,497.93 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 6 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,949.08 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 5 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,422.08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 551 | $248.41 | $136,873.91 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 4 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,338.08 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,264 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889.08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 1,294 | $248.41 | $321,442.54 |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,625.08 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:19 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 2,971 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000160 · wk-form4_1731532733.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,919.08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:09 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 1,473 | $242.69 | $357,482.37 |
DisclosureSEC source: 0001140859-24-000127 · wk-form4_1723061367.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,948.08 Read SEC document |
| June 28, 2024 Filed Jul 5, 2024 20:17 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 66.277 | $191.51 | $12,692.38 |
DisclosureSEC source: 0001140859-24-000111 · wk-form4_1720210645.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,421.08 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| May 29, 2024 Filed Jun 1, 2024 00:54 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 32,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026123 · wk-form4_1717203275.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,082 F1 · shares: Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:43 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 8,415 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000052 · wk-form4_1710362578.xml · derivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,415 Underlying: Common Stock · 8,415 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc. F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 537 | $237.47 | $127,521.39 |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,354.803 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:41 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,891.803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:12 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 52.986 | $174.57 | $9,249.92 |
DisclosureSEC source: 0001140859-24-000008 · wk-form4_1704748350.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,680.803 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:22 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,516 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-23-000193 · wk-form4_1700256157.xml · derivative · entry 4 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,516 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:22 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 4,516 | $196.00 | $885,136.00 |
DisclosureSEC source: 0001140859-23-000193 · wk-form4_1700256157.xml · nonDerivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627.817 Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:22 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 4,516 | $86.09 | $388,782.44 |
DisclosureSEC source: 0001140859-23-000193 · wk-form4_1700256157.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,143.817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:22 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 10,231 | $196.00 | $2,005,276.00 |
DisclosureSEC source: 0001140859-23-000193 · wk-form4_1700256157.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627.817 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.